Tumor specific monoclonal antibodies

Details Tumor specific monoclonal antibodies Tumor specific monoclonal antibodies

A - Human Necessities

61

K

167/129, 195/1.1

A61K 39/00 (2006.01) C07K 16/30 (2006.01) C12N 5/28 (2006.01) C12N 15/08 (2006.01) A61K 38/00 (2006.01)

Patent

CA 1340781

This invention relates to monoclonal antibodies produced by hybridoma or transformed B-cell lines derived from B-cells of cancer patients actively immunized with autologous tumor antigen. These monoclonal antibodies can be used in both diagnostic procedures and therapy for human cancers. This invention also relates to diagnostic procedures and therapeutic approaches using these monoclonal antibodies.

473130

Affiliated with

Also associated with

Rating

Tumor specific monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor specific monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor specific monoclonal antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1295712